EpCAM expression is also related to CD44 and CD166, and the triple-positive (EpCAM+/CD44+/CD166+) markers in NSCLC indicate higher self-renewal ability, clonal heterogeneity, and stemness-associated gene expression (33). This evidence concerns the gene CD44 and non-small cell lung carcinoma.